Top Story

Optovue launches 'entry level' OCT

September 22, 2014

LAS VEGAS – Optovue unveiled its new iScan optical coherence tomographer here at Vision Expo West.

The company’s iWellness software is used to guide the patient through the entire exam with the iScan, requiring minimal operator involvement, according to a press release.

figure Meeting News Coverage

Kreissig Award Lecture highlights AMD research milestones

September 17, 2014
LONDON — The 2014 Kreissig Award was presented to Johanna M. Seddon, MD, ScM, at the Euretina meeting here for her key contributions to research on the etiology…
figure Meeting News Coverage

SAKURA 1 study meets primary endpoint for treatment of noninfectious uveitis

September 15, 2014
LONDON — A study of intravitreal sirolimus for the treatment of noninfectious uveitis has achieved its primary endpoint, a speaker said here, reporting the data…
figure Meeting News Coverage

Retinal atrophy raises concern about long-term anti-VEGF treatment, overdosing

September 14, 2014
LONDON – Anti-VEGF currently remains the best option for preserving vision in AMD patients, but might as a side effect, accelerate atrophy, according to one…
figure

A Fluoroquinolone with Broad Spectrum Antibiotic Potency

This activity is sponsored by Bausch + Lomb.

Watch as leading optometrists discuss the signs and symptoms of bacterial conjunctivitis and weigh various treatment…
More »
Meeting News Coverage Video
figure

VIDEO: OCT, FAF diagnoses peripapillary retinal pigmentary degeneration

May 13, 2014
More »
figure

Bacterial Conjunctivitis Challenge

This activity is sponsored by Sponsored by Bausch + Lomb.

How much do you know about bacterial conjunctivitis treatment? Each question on this challenge features expert…
More »

Filter By:

Meeting News Coverage

Optovue launches 'entry level' OCT

September 22, 2014
LAS VEGAS – Optovue unveiled its new iScan optical coherence tomographer here at Vision Expo West.The company’s iWellness software is…
figure Meeting News Coverage

Kreissig Award Lecture highlights AMD research milestones

September 17, 2014
LONDON — The 2014 Kreissig Award was presented to Johanna M. Seddon, MD, ScM, at the Euretina meeting here for her key contributions to…
figure Meeting News Coverage

SAKURA 1 study meets primary endpoint for treatment of noninfectious uveitis

September 15, 2014
LONDON — A study of intravitreal sirolimus for the treatment of noninfectious uveitis has achieved its primary endpoint, a speaker said here…
figure Meeting News Coverage

Retinal atrophy raises concern about long-term anti-VEGF treatment, overdosing

September 14, 2014
LONDON – Anti-VEGF currently remains the best option for preserving vision in AMD patients, but might as a side effect, accelerate atrophy…
figure Meeting News Coverage

LUCAS study shows equivalence between anti-VEGF drugs following inject-and-extend regimen

September 14, 2014
LONDON – A prospective study comparing the safety and efficacy of anti-VEGF treatment for age-related macular degeneration with ranibizumab and…
figure Meeting News Coverage

Direct-to-consumer genetic tests for AMD risk assessment far from reliable

September 13, 2014
LONDON — Direct-to-consumer genetic tests for age-related macular degeneration, currently widely available via the Internet, cannot provide…
Meeting News Coverage

Ozurdex offers better anatomic outcomes, similar visual acuity vs. anti-VEGF

September 13, 2014
LONDON — For the treatment of patients with persistent diabetic macular edema, Ozurdex demonstrated better anatomic outcomes, but similar…
figure Meeting News Coverage

New INTREPID trial data dispel concerns of radiation-induced microvascular lesions

September 13, 2014
LONDON — Microvascular changes induced by external-beam X-ray therapy for age-related macular degeneration regressed spontaneously and did not…
figure Meeting News Coverage

‘Real-life’ study provides data for anti-VEGF treatment in diverse RVO population

September 12, 2014
LONDON — The LUMINOUS study, the largest prospective, observational study in medical retina, continues to provide a valuable source of real-world…
figure Meeting News Coverage

IOP increase seen with Ozurdex common but easily managed

September 12, 2014
LONDON — A subanalysis of data from the MEAD study showed increased IOP resulting from use of Ozurdex for the treatment of diabetic macular edema was…
More Headlines »